Royalty Pharma Acquires Drug Stake

Royalty Pharma said it acquired an additional interest in Biogen Idec's multiple sclerosis treatment for $510 million.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304617404579304260073197776.html?mod=pls_whats_news_us_business_f

via IFTTT